The Pharmacological Steering and Release group focuses on research into new applications based on nanotechnology to develop innovative pharmacological release therapies, and diagnostic systems to provide solutions to medical needs in the field of oncology and rare diseases. Designing, developing and optimising the nanotechnology system for different uses. The ultimate aim is to transfer this biomedical knowledge to clinical practice in the quickest and most efficient way.

Specifically, it uses in vitro and in vivo models, made-to-measure and image-based (bioluminescent and fluorescent models) to identify new therapeutic targets and address the preclinical validation of therapeutic nanoconjugates and biosensors. With an individualised case study, the group combines basic and translational research, conflating the molecular and cellular basis of the disease with previous studies and allowing new therapies and diagnostic strategies to be designed. 

Visit the research group’s page


Subscribe to our newsletters and be a part of Vall d'Hebron Campus

Select the newsletter you want to receive:

By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to, clearly stating the subject as "Exercising of Data Protection Rights".
Operated by: Vall d’Hebron University Hospital Foundation – Research Institute.
Purpose: Manage the user’s contact information.
Legitimisation: Express acceptance of the privacy policy.
Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use.
Source: The interested party themselves.